Apollon Wealth Management LLC Raises Stake in Kenvue Inc. $KVUE

Apollon Wealth Management LLC boosted its position in Kenvue Inc. (NYSE:KVUE) by 166.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 67,620 shares of the company’s stock after buying an additional 42,246 shares during the period. Apollon Wealth Management LLC’s holdings in Kenvue were worth $1,166,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of KVUE. Arrowstreet Capital Limited Partnership purchased a new stake in Kenvue in the second quarter valued at approximately $6,528,000. Jump Financial LLC boosted its position in Kenvue by 210.6% in the 2nd quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock worth $1,147,000 after purchasing an additional 37,170 shares in the last quarter. AXA S.A. boosted its position in Kenvue by 21.1% in the 2nd quarter. AXA S.A. now owns 48,892 shares of the company’s stock worth $1,023,000 after purchasing an additional 8,524 shares in the last quarter. NewEdge Advisors LLC boosted its position in Kenvue by 219.1% in the 2nd quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock worth $2,040,000 after purchasing an additional 66,930 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its position in Kenvue by 0.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock worth $39,217,000 after purchasing an additional 10,885 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the topic of several recent research reports. Argus upgraded Kenvue to a “hold” rating in a research report on Friday, March 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research note on Wednesday, April 8th. Canaccord Genuity Group upped their target price on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Citigroup upped their target price on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Finally, Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and reduced their target price for the stock from $23.00 to $18.00 in a research note on Friday, January 30th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $19.42.

Kenvue Stock Up 0.7%

Shares of KVUE opened at $17.38 on Wednesday. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a market capitalization of $33.37 billion, a PE ratio of 22.57, a price-to-earnings-growth ratio of 3.92 and a beta of 0.61. The stock has a fifty day simple moving average of $17.96 and a two-hundred day simple moving average of $17.08. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last issued its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. During the same period last year, the company earned $0.26 EPS. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. As a group, equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.